IB

Ibere PharmaceuticalsNYSE IBER Stock Report

Last reporting period 30 Sep, 2022

Updated —

Last price

Market cap $B

0.121

Micro

Exchange

XNYS - New York Stock Exchange, Inc

View Section: Price ratios

Ibere Statements

IB

Data from Ibere`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Sep, 2022

Next reporting period:

29 Dec, 2022

Report frequency:

Quarterly

Earnings release date:

Expected release date:

Ibere Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2022-09-30
%

100

0

0

0

0

0.234

66.2 %

0

-0.234

-66.2 %

0

0.733

0

0.29

0

0.79

-46.4 %

0

0

0.79

-46.4 %

0

0.046

17.25

2022-06-30
%

100

0

0

0

0

0.141

-53.6 %

0

-0.141

53.6 %

0

0.088

0

1.526

0

1.473

-58.8 %

0

0

1.473

-58.8 %

0

0.085

17.25

2022-03-31
%

100

0

0

0

0

0.303

-16 %

0

-0.303

16 %

0

0.003

0

3.873

0

3.573

925.3 %

0

0

3.573

925.3 %

0

0.207

17.25

2021-12-31
%

100

0

0

0

0

0.36

14.2 %

0

-0.36

-14.2 %

0

0.005

0

0.704

0

0.349

-79.9 %

0

0

0.349

-79.9 %

0

0.02

17.276

2021-09-30
%

100

0

0

0

0

0.316

35 %

0

-0.316

-35 %

0

0.003

0

2.043

0

1.731

1642 %

0

0

1.731

1642 %

0

0.1

17.25

2021-06-30
%

100

0

0

0

0

0.234

147.4 %

0

-0.234

-147.4 %

0

0.004

0

0.117

0

-0.112

72.3 %

0

0

-0.112

72.3 %

0

-0.007

17.25

2021-03-31
%

100

0

0

0

0

0.094

0

-0.094

0

0.005

0

-0.316

0

-0.406

0

0

-0.406

0

-0.024

17.25

View Section: Balance Sheet